Aspira Market Capitalization from 2010 to 2024

AWH Stock  USD 0.75  0.02  2.74%   
Aspira Womens' Market Cap is increasing with very volatile movements from year to year. Market Cap is predicted to flatten to about 32.2 M.
Check Aspira Womens financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspira Womens' main balance sheet or income statement drivers, such as Depreciation And Amortization of 189.1 K, Interest Expense of 14.5 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0094 or Days Sales Outstanding of 73.06. Aspira financial statements analysis is a perfect complement when working with Aspira Womens Valuation or Volatility modules.
  
Check out the analysis of Aspira Womens Correlation against competitors.

Latest Aspira Womens' Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Aspira Womens Health over the last few years. It is Aspira Womens' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aspira Womens' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 12.05 M10 Years Trend
Very volatile
   Market Cap   
       Timeline  

Aspira Market Capitalization Regression Statistics

Arithmetic Mean106,853,085
Geometric Mean63,348,880
Coefficient Of Variation152.94
Mean Deviation86,487,528
Median49,386,151
Standard Deviation163,424,565
Sample Variance26707.6T
Range659.2M
R-Value0.06
Mean Square Error28654.5T
R-Squared0
Significance0.83
Slope2,234,401
Total Sum of Squares373906.2T

Aspira Market Capitalization History

202432.2 M
202333.9 M
202137.7 M
2020675.9 M
201970.1 M
201821 M

About Aspira Womens Financial Statements

Investors use fundamental indicators, such as Aspira Womens' Market Capitalization, to determine how well the company is positioned to perform in the future. Although Aspira Womens' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people.

Currently Active Assets on Macroaxis

When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:
Check out the analysis of Aspira Womens Correlation against competitors.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
0.801
Quarterly Revenue Growth
(0.03)
Return On Assets
(1.86)
Return On Equity
(7.23)
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.